Same-day Post-Therapy Imaging with a New Generation Whole-Body Digital SPECT/CT in Assessing Treatment Response to [177Lu]lu-Psma-617 in Metastatic Castration-Resistant Prostate Cancer.
European Journal of Nuclear Medicine and Molecular Imaging（2024）
Key words
Metastatic castration resistant prostate cancer,Lutetium-PSMA,SPECT/CT,Treatment response biomarker
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined